【文獻標題】Mesenchymal stem cells upregulate Treg cells via sHLA-G in SLE patients

【作者】Chen Chen，Jun Liang，Genhong Yao，et.al

【作者單位】南京大學醫學院附屬鼓樓醫院（ The Affiliated Drum Tower Hospital of Nanjing University Medical School）

【文獻中引用產品】

小鼠Qa淋巴細胞抗原2（Qa-2）elisa試劑盒

【關鍵詞】Human leukocyte antigen-G，SLE，Mesenchymal stem cells，Treg

【DOI】http://dx.doi.org/10.1016/j.intimp.2017.01.024

【影響因子(IF)】5.10

【出版期刊】《International Immunopharmacology》

【產品原文引用】

The following antibodies ａnd their isotype-matched controls (to human) were from eBioscience (San Diego, CA, USA): fluorescein isothiocyanate (FITC)-conjugated anti-human CD4 (OKT3), phycoerythrin (PE)-conjugated anti-human ILT2 (HP-F1), Foxp3 (PCH101),allophycocyanin (APC)-conjugated anti-human CD25 (BC968), CD19 (HIB19), CD8 (RPA-T8). Purified anti-human HLA-G antibodies were from BioLegend (San Diego, CA, USA). The sHLA-G ELISA kit was from USCN (Wuhan, Hubei, China). The mouse Qa-2 ELISA kit was from Shanghai HengYuan Biological Technology Co. (Shanghai, China).

完整版PDF文獻請咨詢在線客服或者電話聯系我司業務員！

更多公司福利請關注“恒遠生物”微信公眾號！

原創作者：上海恒遠生物科技有限公司